News
Alnylam Pharmaceuticals, Inc. , the leading RNA interference (RNAi) therapeutics company, today announced that the European Commission (EC) has granted approval for the treatment of wild-type or ...
Canadian Grand Prix in Montreal marks a crucial point in a competitive F1 season. Oscar Piastri leads the Drivers' ...
Discover why the U.S. Securities and Exchange Commission changed penny stock definitions from $1 to $5 per share and how it ...
Critics say the measures include excluding some spending from review by state Comptroller Thomas DiNapoli, avoiding ...
Canada aims to meet NATO's defence spending target. Prime Minister Mark Carney made the announcement. The investment totals ...
Congress, its eye on a futuristic form of finance, is debating legislation that would legitimize stablecoins, a specific type of cryptocurrency linked to the U.S. dollar.
3hon MSN
Not too long ago, I finally got to watch Nickel Boys, and even more recently, I got to watch the Nicolas Cage movie. That ...
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 ...
Netflix went all out when it hosted its third Tudum event recently, the first to stream live globally. Named after the ...
EU countries are starting to speak out regarding Israel due to pressure from their populations. Yet it remains to be seen if ...
Company to host conference call and webcast today at 8:00 A.M. ET ...
Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination Well-t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results